2022-05-26-MLNC - Biosimilars: Interchangeable Products May Increase Patient Access

by  CMS - MLNConnects
June 16th, 2022





COVID-19: New Administration Code for Pfizer Pediatric Vaccine Booster Dose

On May 17, 2022, the FDA amended the Pfizer-BioNTech COVID-19 vaccine emergency use authorization (PDF) to authorize the use of a single booster pediatric dose (orange cap) for all patients 5–11 years old. CMS issued a new code, effective May 17, 2022, for the vaccine administration:

Code: 0074A

For more information, visit the COVID-19 Provider Toolkit, and get the most current list of billing codes, payment allowances, and effective dates. (Note: you may need to refresh your browser if you recently visited these webpages). 

Biosimilars: Interchangeable Products May Increase Patient Access

Depending on state pharmacy laws, you may substitute an interchangeable biosimilar product at the pharmacy, much like substituting a generic for a brand-name drug. This helps increase patient access to biologics and may reduce patient costs. Learn more about Interchangeable Biological Products from the FDA. Bookmark FDA’s Biosimilars webpage and materials for health care providers and patients.

Additional FDA resources you may find helpful:

Critical Care Evaluation & Management Services: Comparative Billing Report in May

In late May, CMS will issue a Comparative Billing Report (CBR) on Medicare Part B claims for critical care evaluation and management services. Use the data-driven report to compare your billing practices with those of peers in your state and across the nation.

CBRs aren’t publicly available. Look for an email from cbrpepper.noreply@religroupinc.com to access your report. Update your email address in PECOS to make sure you get it.

More Information:


Surgical Dressings: Medicare Requirements

Medicare covers primary or secondary surgical dressings:

You must:

For more information, see the Surgical Dressings – Policy Article.


Screening Pap Tests & Pelvic Exams — Revised

Learn about 3 new ICD-10 diagnosis codes for these screenings (PDF):


This newsletter is current as of the issue date. View the complete disclaimer.



2022-05-26-MLNC - Biosimilars: Interchangeable Products May Increase Patient Access. (2022, June 16). Find-A-Code Articles. Retrieved from https://www.findacode.com/articles/2022-05-26-mlnc-biosimilars-interchangeable-products-may-increase-patient-access-37084.html

© InnoviHealth Systems Inc

Article Tags  (click on a tag to see related articles)

Publish this Article on your Website, Blog or Newsletter

This article is available for publishing on websites, blogs, and newsletters. The article must be published in its entirety - all links must be active. If you would like to publish this article, please contact us and let us know where you will be publishing it. The easiest way to get the text of the article is to highlight and copy. Or use your browser's "View Source" option to capture the HTML formatted code.

If you would like a specific article written on a medical coding and billing topic, please Contact Us.


innoviHealth Systems, Inc.
62 East 300 North
Spanish Fork, UT 84660
Phone: 801-770-4203 (8-5 Mountain)
free demo
request yours today
free subscription
for any budget

Thank you for choosing Find-A-Code, please Sign In to remove ads.